The honorary degrees have been handed out every year since 1967, making this the 44th annual ceremony, and can be bestowed upon both Hungarian and foreign professors who have strong professional ties with Semmelweis University. In total, the university now has awarded the honor to 268 notable professors.
This year, four professors nominated by the Faculty of Medicine received the Doctor Honoris Causa Award, two were put forward by the Faculty of Pharmacy, and one each proposed for the honor by the Faculty of Health Sciences and the School of PhD Studies.
The laudations of the nominees, their scientific achievements and their professional collaboration with Semmelweis University, were delivered by the deans of the respective nominating faculties.
Following the laudations, Dr. Béla Merkely, Dr. László Hunyady, Dr. Romána Zelkó, Dr. Nagy Zoltán Zsolt and Dr. Tímár József handed over the awards and stoles to all the awardees, after which the eight professors held their ceremonial speeches.
In his closing remarks, Rector Merkely said he hopes that the awardees will continue their collaboration with Semmelweis University and help to promote its good reputation abroad.
The following professors received the Doctor Honoris Causa Award in 2018:
Nominated by the Faculty of Medicine, laudations by Professor László Hunyady, Dean
Dr Piotr L. Chlosta, Professor and Chairman of the Department of Urology of the Jagiellonian University in Krakow, President of the Polish Urological Association. An accomplished urological surgeon, he has cooperated since 2012 with the Department of Urology at Semmelweis University on organizing Hungarian-Polish Scientific Sessions in the USA.
Dr Miklós Sahin-Tóth is a prominent, internationally recognized translational researcher, a renowned representative of his chosen field of research. He is currently the Director of the Center for Exocrine Disorders at Boston University. He has had strong collaborative ties with the Department of Medical Chemistry, Molecular Biology and Pathobiochemistry of Semmelweis University for the past 15 years.
Dr Scott David Solomon is a world-renowned cardiac surgeon, Professor of Medicine at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital. He pioneered the use of cardiac imaging in cardiovascular drug and device development and use of imaging in clinical trials. He has collaborated with Semmelweis University’s Heart and Vascular Center for more than a decade.
Dr. Maria Antonietta Stazi is a genetic epidemiologist at the Istituto Superiore di Sanita in Rome as well as the founder and leader of the Italian Twin Registry. She has worked together on twin research projects with the Department of Radiology of Semmelweis University in the past ten years.
Nominated by the Faculty of Pharmacy, laudations by Professor Romána Zelkó, Dean
Dr Daan J.A. Crommelin is a professor emeritus of Biopharmaceutics at the Department of Pharmaceutics at Utrecht University. He has published extensively, in particular on novel drug delivery systems for targeted delivery of biotech-based medicines. He has been on the advisory committee and spoke at all three International Symposia on Scientific and Regulatory Advances in Complex Drugs in Budapest since 2014.
Dr. Olavi Pelkonen, Professor of Pharmacology, University of Oulu in Finland. He has more than 400 original and review articles in international scientific journals, mainly on various aspects of drug and carcinogen metabolism. Since his retirement in 2010, he has continued his work at national and EU levels and is currently a Panel member at EFSA since 2015.
Nominated by the Faculty of Health Sciences, laudation by Professor Zoltán Zsolt Nagy, Dean
Dr. Jianguang Xu, President of Shanghai University of Traditional Chinese Medicine (Shanghai TCM), professor of the Hand Surgery Department of Huashan Hospital. Representing Shanghai TCM, he signed an agreement with Semmelweis University in 2016, aimed at improving cooperation in the fields of training and staff exchange. Lecturers of the Shanghai university will soon be involved in teaching traditional Chinese medicine subjects at Semmelweis University.
Nominated by the School of PhD Studies, laudation by Professor József Tímár, President of the Doctoral Council
Dr. Stefan Offermanns, Director of the Max Planck Institute for Heart and Lung Research, Department of Pharmacology and Professor at the J.W. Goethe University Frankfurt. He has a distinguished scientific career, dealing primarily with G-protein-coupled receptors (GPCRs). In the last 16 years, he has hosted in his research group several PhD students and postdoctoral fellows from the Institute of Clinical Experimental Research of Semmelweis University.
Source: Semmelweis University